Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Juan F. Gallegos‐Orozco, Velimir A. Luketic et al.|Gastroenterology|2016Cited by 1k
The natural history of classic galactosemia: lessons from the GalNet registryM. Estela Rubio‐Gozalbo, Gerard T. Berry, Minela Haskovic et al.|Orphanet Journal of Rare Diseases|2019Cited by 147
Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): Literature review and report of new casesDavid Cassiman, Gerald F. Cox, Seymour Packman et al.|Molecular Genetics and Metabolism|2016Cited by 122
Sorbitol Is a Severity Biomarker for <scp>PMM2‐CDG</scp> with Therapeutic ImplicationsAnna N. Ligezka, Éva Morava, Silvia Radenkovic et al.|Annals of Neurology|2021Cited by 57
SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 PatientsEvan C. Ray, David Cassiman, Cary R. Boyd‐Shiwarski et al.|Kidney Medicine|2020Cited by 51